2025

Get Ready to Geek Out: ACELYRIN INC. Invites You to a Virtual Investor Event for an Exclusive Sneak Peek at Exciting Phase 2 Data and Phase 3 Program Plans for Subcutaneous Lonigutamab!

newsit04 mins

Welcome to the Future of Medicine Los Angeles, Jan. 02, 2025 – In a groundbreaking announcement, Acelyrin, Inc. has revealed plans to showcase updated Phase 2 data for their latest medicine, lonigutamab, during a virtual investor event on Monday, January 6, 2025. This event is set to shed light on the potential of lonigutamab in…

Read More

Breaking News: S&P Dow Jones Indices Releases New Guidelines for S&P Composite 1500 Market Cap

marketinsider04 mins

S&P Dow Jones Indices Updates Market Capitalization Eligibility Criteria Introduction On January 2, 2025, S&P Dow Jones Indices (“S&P DJI”) announced a significant update to the market capitalization eligibility criteria for companies being added to the S&P Composite 1500 Indices. These changes, set to take effect immediately, will impact the composition of the S&P 500,…

Read More

Dogecoin (DOGE) Surges Overnight, Causing 400 Liquidations to Shock Market

newsit04 mins

Trading Activity Surrounding Dogecoin Anomalous Trading Behavior Recently, the trading activity revolving around the major meme cryptocurrency of the market, Dogecoin (DOGE), has raised eyebrows among investors and analysts. A notable abnormality that caught the attention of many was the significant imbalance in liquidations of DOGE perpetual futures positions. This peculiar phenomenon was brought to…

Read More